Wolverine Trading
VIVO

Wolverine Trading’s Meridian Bioscience Inc VIVO Stock Holding History

Wolverine Trading’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,606
Closed -$145K – 5178
2017
Q1 		$145K Buy
+10,606
New +$148K ﹤0.01% 3701

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's VIVO Position: Q2 2017 in Review

Wolverine Trading sold out of Meridian Bioscience Inc (VIVO) in Q2 2017, closing a stake of 10,606 shares — an estimated $145K sold.

Wolverine Trading first reported a position in VIVO in Q1 2017 and held it in 1 quarter. The position peaked at $145K in Q1 2017. 170 funds tracked by Wall St. Rank hold VIVO as of Q2 2017.

  • Wolverine Trading reported no remaining Meridian Bioscience Inc position as of Q2 2017 after selling out during the quarter.
  • Wolverine Trading sold 10,606 Meridian Bioscience Inc shares in Q2 2017, an estimated $145K.
  • Wolverine Trading first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 1 quarter.
  • Wolverine Trading's Meridian Bioscience Inc position peaked at $145K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2017.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.